Webinar on Bladder EpiCheck®, for NMIBC monitoring

Webinar on Bladder EpiCheck®, for NMIBC monitoring

On Tuesday October 6th  2020, Nucleix, Israel and Palex Medical, Spain organised the webinar “Bladder EpiCheck®, for accurate, non-invasive bladder cancer monitoring”. Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands,...
Interested in the place of urinary markers in NMIBC follow-up?

Interested in the place of urinary markers in NMIBC follow-up?

Watch a webinar by Prof. Fred Witjes On Thursday 24 September 2020, Nucleix, Israel and Oncotest-Rhenium, Israel organised the webinar “Follow-up of NMIBC, Including the Place of Urinary Markers”. The webinar included 45 minutes lecture by Prof. Dr. Fred Witjes,...
Methylation-based assay & TPS reporting of urine cytology

Methylation-based assay & TPS reporting of urine cytology

Reviewed by Joost Boormans (Erasmus MC Cancer Institute, Rotterdam, the Netherlands)   Data from a recent study support the use of a urinary methylation-based assay, i.e. Bladder EpiCheck®, to accurately identify recurrence in patients with high-grade...